The Liquid Biopsy Market size is USD 4.1 billion in 2026.
The Liquid Biopsy Market is projected to grow at a CAGR of 6.80% by 2033.
The Liquid Biopsy Market growth drivers include rising cancer prevalence, advancements in NGS and AI technologies, and growing demand for non-invasive diagnostics.
North America is a dominating region for the Liquid Biopsy Market.
Guardant Health, Grail (Illumina), Hoffmann-La Roche, Qiagen, and Exact Sciences are some leading industry players in the Liquid Biopsy Market.